High MDA and IL-1β levels were maintained in grafts from DBDs treated with GH or VEGFB (BD + GH + CI/R and BD + VEGFB + CI/R groups), showing oxidative stress and inflammatory activity in those grafts, and was only diminished in the livers of rats administered VEGFA (BD + VEGFA + CI/R group), indicating the benefits of VEGFA on IL-1β levels. This evidence concerns the gene VEGFB and Behcet disease.